A combinatorial strategy for treating KRAS-mutant lung cancer-Reference-Cited by-同舟云学术

A combinatorial strategy for treating KRAS-mutant lung cancer

Published:2016-06-22 Issue:7609 Volume:534 Page:647-651
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Manchado Eusebio,Weissmueller Susann,Morris John P.,Chen Chi-Chao,Wullenkord Ramona,Lujambio Amaia,de Stanchina Elisa,Poirier John T.,Gainor Justin F.,Corcoran Ryan B.,Engelman Jeffrey A.,Rudin Charles M.,Rosen Neal,Lowe Scott W.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature18600.pdf

Reference36 articles.

1. Downward, J. Targeting RAS signalling pathways in cancer therapy. Nature Rev. Cancer 3, 11–22 (2003)

2. Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A. & Shokat, K. M. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature 503, 548–551 (2013)

3. Barbie, D. A. et al. Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462, 108–112 (2009)

4. Scholl, C. et al. Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell 137, 821–834 (2009)

5. Luo, J. et al. A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. Cell 137, 835–848 (2009)

Cited by 334 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Wnt/β-catenin pathway in cancer drug resistance: Insights into molecular aspects of major solid tumors;Biochemical and Biophysical Research Communications;2024-10

2. Exosomes-based immunotherapy for cancer: Effective components in the naïve and engineered forms;International Immunopharmacology;2024-09

3. Identification of clinical prognosis features and significant DNA methylation regulation in pineoblastoma;International Journal of Clinical Oncology;2024-08-30

4. Triple Blockade of Oncogenic RAS Signaling Using KRAS and MEK Inhibitors in Combination with Irradiation in Pancreatic Cancer;International Journal of Molecular Sciences;2024-06-06

5. Mesoporous silica nanoparticles: a versatile carrier platform in lung cancer management;Nanomedicine;2024-05-20